Performance of Blood-Based Screening Algorithm for Predicting AD Pathology and Baseline Characteristics of Participants in a Phase 2 Trial of Etalanetug and Concurrent Lecanemab
Doherty et al
Performance of Blood-Based Screening Algorithm for Predicting AD Pathology and Baseline Characteristics of Participants in a Phase 2 Trial of Etalanetug and Concurrent Lecanemab
